Merck Lifts FY Revenue Guidance

Merck Lifts FY Revenue Guidance

Merck shares rose 1% in pre-market trade after the pharmaceutical company reported Q2 adjusted earnings of $1.01, up from $0.93 in the same period a year ago and topping the estimate of $0.87 from analysts polled by CapIQ. Total revenues of $9.93 billion were up from $9.84 billion in the same period a year ago and exceeded the Street projection of $9.75 billion. Merck maintained its FY adjusted EPS guidance […]

Read More ˃